PolyPeptide Group

Torrance, CA · Strasbourg, FR · Malmo, SE
Find alternatives to PolyPeptide Group for Oligonucleotide →
Program data pending ClinicalTrials.gov matching · Last scored 2026-11-12
77.4
Signal Score
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ✓ Press (7) ○ EMA GMP ○ MHRA GMP ✓ HC GMP (10)

Quick Facts: PolyPeptide Group

Signal Score
77.4/100 (as of 2026-11-12)
Quality Compliance
98.4/100
Headquarters
Torrance, CA · Strasbourg, FR · Malmo, SE
Modalities
Oligonucleotide
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About PolyPeptide Group

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 98.4
FDA Inspections3 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-05-15)
Most Recent HC OutcomeCompliant · 2024-05-07
HC Attribution10 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesOligonucleotide
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
3 manufacturing sites
Sites: Torrance, CA, Strasbourg, FR, Malmo, SE
Source: company profiles (manufacturing sites, modality breadth)
3 manufacturing sites
Press Signals7 articles (not scored)
3 manufacturing sites

PolyPeptide Group FDA Inspection History

2025-05
2024-05
2021-11
NAI VAI OAI
Date Site Type 483 citations posted Classification
2025-05-15
PolyPeptide Laboratories San Diego LLC
San Diego, California Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2024-05-10
PolyPeptide Laboratories, Inc.
Torrance, California Company-level
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2021-11-19
PolyPeptide Laboratories, Inc.
Torrance, California Company-level
Drug Quality Assurance Not posted No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

general (non-sterile) · 2 sites

  • Strasbourg, France · PolyPeptide Laboratories France SAS — general (non-sterile) · valid to Jul 12, 2031
  • Torrance, United States · PolyPeptide Laboratories, Inc. — general (non-sterile) · valid to Dec 3, 2026 renewal filed
Previously accredited (cancelled) · 1
  • San Diego, United States · Polypeptide Laboratories San Diego — general (non-sterile) · cancelled Apr 7, 2021

No longer on PMDA's current list. Shown for history only; not used in search tags.

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity 33 open roles Beta

From public job postings on PolyPeptide Group's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
33
open roles
22
in manufacturing, quality, PD/MSAT, engineering or regulatory (67%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 1 new posting, 1 taken down.
By function
Manufacturing & operations 6
Quality (QA / QC) 12
Process development & MSAT 2
Engineering & facilities 2
Commercial, BD & client projects 3
Other (finance, HR, IT, other) 8
By site
Strasbourg, France profile site
3 mfg/ops · 4 QA/QC · 1 eng. · 3 other
11
Torrance, CA, United States profile site
2 mfg/ops · 3 QA/QC · 2 PD/MSAT · 2 other
9
Malmö, Sweden profile site
· 3 QA/QC · 1 eng. · 3 other
7
Ambernath, India
· 2 other
2
Braine-l'Alleud, Belgium
1 mfg/ops · 1 other
2
San Diego, United States profile site
· 2 QA/QC
2
Notable roles
Head of Quality Assurance - Torrance Senior operations / quality role · Torrance, CA, United States
Latest postings
Technicien HSE - (CDI) Other (finance, HR, IT, other) · Strasbourg, France · posted Nov 19, 2026
2630102 & 103 - Production Chemist - Torrance Quality (QA / QC) · Torrance, CA, United States · posted Nov 18, 2026
QC Manager Starting & Raw Material Release Quality (QA / QC) · Malmö, Sweden · posted Nov 11, 2026
Assistant Manager - M&E Other (finance, HR, IT, other) · Ambernath, India · posted Nov 6, 2026
Technicien de laboratoire Contrôle Qualité IPC - Posté 2X8 - (CDI) Quality (QA / QC) · Strasbourg, France · posted Nov 4, 2026
Senior Industrial Microbiology Specialist Quality (QA / QC) · Malmö, Sweden · posted Nov 4, 2026
Chargé de projets RH confirmé - (CDD) Other (finance, HR, IT, other) · Strasbourg, France · posted Nov 3, 2026
Senior Lead Investigator Manufacturing & operations · Braine-l'Alleud, Belgium · posted Oct 22, 2026
Automationsingenjör Engineering & facilities · Malmö, Sweden · posted Nov 2, 2026
IT/OT Technician - Torrance Other (finance, HR, IT, other) · Torrance, CA, United States · posted Oct 30, 2026
Commercial Supply Chain Manager Commercial, BD & client projects · Braine-l'Alleud, Belgium · posted Oct 22, 2026
Quality Coordinator Other (finance, HR, IT, other) · Malmö, Sweden · posted Oct 7, 2026
Coverage: counted from PolyPeptide Group's own careers board. Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source: careers.polypeptide.com · Checked Nov 20, 2026 · Tracking since Oct 26, 2026

Company Signals 7 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-04-14
PolyPeptide Group AG takes note of market rumors and speculation - TradingView — Track All Markets
PolyPeptide Group AG takes note of market rumors and speculation  TradingView
general 2026-04-14
PolyPeptide explores options as EQT, Advent, and KKR show interest - pe-insights.com
PolyPeptide explores options as EQT, Advent, and KKR show interest  pe-insights.com
general 2026-04-08
PolyPeptide announces results of the annual General Meeting 2026 - TradingView
PolyPeptide announces results of the annual General Meeting 2026  TradingView
general 2026-04-08
PolyPeptide announces results of the annual General Meeting 2026 - AD HOC NEWS
PolyPeptide announces results of the annual General Meeting 2026  AD HOC NEWS
general 2026-03-17
PolyPeptide publishes invitation to the annual General Meeting 2026 - TradingView
PolyPeptide publishes invitation to the annual General Meeting 2026  TradingView
general 2026-03-17
PolyPeptide Group / CH1110760852 - AD HOC NEWS
PolyPeptide Group / CH1110760852  AD HOC NEWS
financial 2026-03-11
PolyPeptide delivers strong revenue growth and marked improvement in profitability - TradingView
PolyPeptide delivers strong revenue growth and marked improvement in profitability  TradingView

Frequently Asked Questions About PolyPeptide Group

How many FDA inspections does PolyPeptide Group have on record?
CDMO Signal tracks 3 FDA inspections for PolyPeptide Group, sourced from the FDA inspection database. See the full inspection history above.
Has PolyPeptide Group received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for PolyPeptide Group.
What is PolyPeptide Group's CDMO Signal Score?
PolyPeptide Group has a Signal Score of 77/100, based on quality, operations, financial stability, and capacity data.
Evaluating PolyPeptide Group for a manufacturing program?
Use the free AI matchmaker to compare PolyPeptide Group against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs →

Similar CDMOs

Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Agilent Technologies (Oligo GMP)
Boulder, CO · Frederick, CO
Signal Score: 74.2
Oligonucleotide
TriLink BioTechnologies
San Diego, CA
Signal Score: 63.0
mRNA, Oligonucleotide

Compare PolyPeptide Group with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on PolyPeptide Group
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.